Novo Nordisk Long Term Debt 2010-2024 | NVO

Novo Nordisk long term debt for the quarter ending December 31, 2024 was $13.003B, a 336.24% increase year-over-year.

  • Novo Nordisk long term debt for 2024 was $13.003B, a 336.24% increase from 2023.
  • Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
  • Novo Nordisk long term debt for 2022 was $3.443B, a 66.99% increase from 2021.

Novo Nordisk Long Term Debt 2010-2024 | NVO

  • Novo Nordisk long term debt for 2024 was $13.003B, a 336.24% increase from 2023.
  • Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
  • Novo Nordisk long term debt for 2022 was $3.443B, a 66.99% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B